Le Lézard
Classified in: Environment, Covid-19 virus

The EU Green Deal & Energy Transition in Southeast Europe 2020: A Country-by-Country Overview - ResearchAndMarkets.com


The "The EU Green Deal & Energy Transition in Southeast Europe" report has been added to ResearchAndMarkets.com's offering.

In the age of a necessary urgent climate and sustainability action, now further amplified by the COVID-19 health crisis and the economic slump which it entails, the decade ahead and the EU's Green Deal is pivotal for the SEE energy sector's transformation and the region's economic recovery as a whole.

This report gives insights on the region's progress towards sustainable energy and assesses the risks stemming from this transformation. It also provides two case-studies on corporate green investments to support decision-makers who seek to leverage on green energy to make sustainable investments.

The report includes:

The report covers 12 economies in SEE:

The financial analysis of the coal industry covers 11 markets (excluding Moldova) and is based on several factors, including:

Key Topics Covered

1. The Road from EE's 20/20/20 Targets to the Green Deal and the 2030 Decade

2. Energy Transition Plans of EE Member States in SEE

3. Energy Transition in the Western Balkans

4. The Business Case for Corporate Green Investments

5. Love Affair with Coal in Time of Green Deal

6. COVID-19 and the Green Deal

Companies Mentioned

For more information about this report visit https://www.researchandmarkets.com/r/ha7iku


These press releases may also interest you

at 01:20
Biophytis SA (Euronext Growth Paris:ALBPS), ("Biophytis" or the "Company"), a clinical-stage biotechnology company specialized in thedevelopment oftherapeutics for age-related diseases, today annouces that it will change the ratio...

18 avr 2024
The report titled "Clinical Trials Matching Software Market by Functionality (Analytics & Reporting, Compliance Tracking, Data Management), Deployment (Cloud & Web Based, On-Premise), End-Use - Global Forecast 2024-2030" is now available on...

18 avr 2024
South Korea's biotechnology company Hyundai Bioscience (CEO Oh Sang-gi, www.hyundaibioscience.com) announced on April 15 that it would carry out global clinical tests aimed at treating all serotypes of Dengue virus infection....

18 avr 2024
The economic turmoil triggered by the COVID-19 pandemic has led to a sharp decrease in the number of self-employed individuals in the United States, with a 22% reduction...

18 avr 2024
WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of common stock of QuidelOrtho Corporation between February 18, 2022 and April 1, 2024, both dates inclusive (the "Class...

18 avr 2024
Takeda (TSE:4502/NYSE:TAK) today announced that the U.S. Food and Drug Administration (FDA) has approved ENTYVIO® (vedolizumab) subcutaneous (SC) administration for maintenance therapy in adults with moderately to severely active Crohn's disease (CD)...



News published on and distributed by: